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Abstract
Background: Oestradiol is a steroid hormone that exerts extensive influence on brain development and is a
powerful modulator of hippocampal structure and function. The hippocampus is a critical brain region regulating
complex cognitive and emotional responses and is implicated in the aetiology of several mental health disorders,
many of which exhibit some degree of sex difference. Many sex differences in the adult rat brain are determined
by oestradiol action during a sensitive period of development. We had previously reported a sex difference in rates
of cell genesis in the developing hippocampus of the laboratory rat. Males generate more new cells on average
than females. The current study explored the effects of both exogenous and endogenous oestradiol on this sex
difference.
Methods: New born male and female rat pups were injected with the mitotic marker 5-bromo-2-deoxyuridine
(BrdU) and oestradiol or agents that antagonize oestradiol action. The effects on cell number, proliferation,
differentiation and survival were assessed at several time points. Significant differences between groups were
determined by two- or thee-Way ANOVA.
Results: Newborn males had higher rates of cell proliferation than females. Oestradiol treatment increased cell
proliferation in neonatal females, but not males, and in the CA1 region many of these cells differentiated into
neurons. The increased rate of proliferation induced by neonatal oestradiol persisted until at least 3 weeks of age,
suggesting an organizational effect. Administering the aromatase inhibitor, formestane, or the oestrogen receptor
antagonist, tamoxifen, significantly decreased the number of new cells in males but not females.
Conclusion: Endogenous oestradiol increased the rate of cell proliferation observed in newborn males compared
to females. This sex difference in neonatal neurogenesis may have implications for adult differences in learning
strategy, stress responsivity or vulnerability to damage or disease.
Introduction
Sex differences in the brain are widespread but of vari-
able magnitude. Differences in the size of specific struc-
tures or subnuclei are well characterized, as are sex
differences in the density and number of excitatory and
inhibitory synapses within particular brain regions.
Many sex differences in the brain are induced during a
perinatal sensitive period by oestradiol following its cen-
tral aromatization from testicularly derived androgen
precursors (for review see [1]). The most robust
neuroanatomical sex differences are found in the brain
areas directly involved in reproduction, such as the pre-
optic area, hypothalamus and spinal cord [2-6]. The
impact of steroids on these brain regions across the life-
span is codified in the Organizational/Activational
Hypothesis of sexual differentiation first postulated over
50 years ago [7]. Gonadal steroids, including oestradiol,
also potently regulate synaptic profiles in adult brain
regions not directly associated with reproduction, such
as the hippocampus [8-10] and the amygdala [11].
The hippocampus subserves important behavioural and
physiological functions that are influenced by sex. There
are subtle, identifiable, sex differences in hippocampal
volume [12] and the morphology of hippocampal
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any medium, provided the original work is properly cited.cells [13-15]. There are also subtle sex differences in hip-
pocampal associated behaviours such as spatial learning
strategies, stress responsivity, and the long-term impact
of negative early life events [16-20]. There are also subtle
but complex sex differences in the developing hippocam-
pus that are associated with parameters responsive to
oestradiol, including calcium entry in response to depo-
larizing GABA [21-24] and cell genesis [25].
The hippocampus is comprised of subregions (for
example, dentate gyrus (DG), CA1 and CA3) and each
subregion contains distinctive cell types characterized by
distinctive rates of maturation. The pyramidal cells, the
principle cells of Ammon’s horn, are largely formed
before birth [26-29]. In contrast, granule cells, which
comprise the major cell type found in the DG, are predo-
minantly born during the first 2 weeks of postnatal life
[28,30]. The development of granule cells in the molecu-
lar layer of the DG is faster in males than females [30],
suggesting a sex difference in cell proliferation.
Hormonally-mediated sex differences in cell death are
central to the sexual differentiation of many brain areas
(for review see [31]), but less is known about sex differ-
ences in cell genesis, particularly during development.
However, we recently reported that neonatal males have
more new cells as indicated by 5-bromo-2-deoxyuridine
(BrdU) in the DG and CA1, relative to females, with no
corresponding sex difference in the number of pyknotic
cells [25]. Both oestradiol and testosterone treatment
increase the number of BrdU+ cells in females to the
level found in males. However, whether endogenous
steroids mediate the sex difference in cell proliferation
is unknown. It is also unknown whether developmental
steroid effects on cell proliferation are transient or orga-
nized and, as a result, endure across the lifespan. Here
we report that endogenous oestradiol can generate
higher rates of cell proliferation in males but plays no
role in females. Consistent with previous results, treat-
ment of females with exogenous oestradiol increases cell
proliferation both acutely and 3 weeks later, suggesting
that oestradiol might have an organizational role in neu-
rogenesis. The sex difference in neurogenesis reported
here may reflect a critical time period in hippocampal
development that contributes to sexual dimorphisms in
the adult hippocampus.
Methods
Animals
Newborn male and female Sprague-Dawley rats were
obtained from breeder females at the University of
Maryland School of Medicine. The day of birth was
defined as postnatal day 0 (PN0). The animals were
housed under a 12:12 h light: dark cycle, with food and
water freely available. All procedures were approved by
the University of Maryland School of Medicine
Institutional Animal Care and Use Committee and
followed National Institutes of Health Guidelines.
Hormonal treatment of animals
On PN0, male and female rat pups were randomly dis-
tributed into different experimental groups and marked
for identification by a subcutaneous (sc) ink injection in
either the front or hind paws and injected sc with either
oestradiol benzoate (100 μg ⁄ 0.1 mL in sesame oil), for-
mestane (100 μg ⁄ 0.1 mL in sesame oil), tamoxifen
(100 μg ⁄ 0.1 mL in sesame oil) or vehicle (sesame oil;
see Figure 1 for the experimental timeline). The high
dose of oestradiol is required in order to overcome the
sequestering capacity of alpha-fetoprotein in the neona-
tal bloodstream [2] and is a dose routinely used by this
laboratory to induce sexual differentiation of reproduc-
tive parameters [32]. Moreover, benzoate moiety does
not alter the oestradiol’s biological activity but does pro-
long its bioavailability. The dose of formestane has been
previously used in this laboratory to decrease endogen-
ous oestradiol in the neonatal brain to near undetectable
levels [2]. The dose of tamoxifen was based on pre-
viously published literature using this drug in vivo [33].
Both formestane and tamoxifen readily cross the blood-
brain-barrier [34,35]. Two hours after the steroid injec-
tion, all pups were injected intraperitoneally (ip) with
B r d Uo nP N 0a n dP N 1( 0 . 1m L0 . 9 %s t e r i l es a l i n ec o n -
taining 100 mg ⁄ kg of BrdU), except for the experiments
in which animals were injected with BrdU only on PN0.
The rationale for administering BrdU 2 hours post hor-
mone injection was based on previously published work
in our laboratory in which a hormonal effect on BrdU+
cells was observed [25]. The injection sites were sealed
with cyanoacrylate Vetbond Surgical Adhesive (3 M
Animal Care Product, MN, USA).
Tissue collection
Pups were deeply anaesthetized with sodium pentobarbi-
tal Fatal Plus (250 mg/kg) and transcardially perfused
with 0.9% saline until there was no blood trace and then
fixed with 4% paraformaldehyde (PFA). Brains were
r e m o v e da n df i x e df o r2 4hi n4 %P F A ,f o l l o w e db y4 8
h in 30% sucrose in PFA before being sectioned coron-
ally on a cryostat, with each slice being 45 μmt h i c k .
Slices used for quantification were separated from each
other along the rostral/caudal axis so that two contigu-
ous sections were not analysed in the same animal.
Sections were collected in series such that each animal
generated 4-5 series of sections with 6-8 sections per
series obtained from each brain.
Immunohistochemistry
Free-floating tissue sections were rinsed with 0.1 M
phosphate buffered saline (PBS) and then incubated
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Page 2 of 13Figure 1 Timeline for 5-bromo-2-deoxyuridine (BrdU) injections and hormone treatments for each experiment. (A) Sex differences and
the effects of oestradiol on cell proliferation were tested by postnatal day (PN) 0 hormone treatment with euthanasia 6 h after injection of BrdU.
(B) Sex differences and the effects of oestradiol on short-term cell survival were tested by PN0 hormone treatment followed by euthanasia at
PN4. (C) Sex differences and the effects of oestradiol on long-term survival and cell fate were tested by PN0 and PN1 hormone and BrdU
treatments followed by euthanasia at PN21 and IHC processing for BrdU+cells. (D) Sex differences and the effects of antagonizing endogenous
oestradiol were tested by treatment on PN0 and PN1 with formestane, tamoxifen or vehicle and BrdU followed by euthanasia at PN2 and IHC
processing for BrdU+ cells.
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Page 3 of 13with 3% hydrogen peroxide in PBS for 30 min. For BrdU
immunohistochemistry, tissue sections were further
incubated with 2N hydrogen chloride (HCl) for 60 min
at 37°C in order to denature the DNA. After HCl incu-
bation, the sections were rinsed with Borate buffer solu-
tion followed by PBS rinses. Finally, sections were
incubated with 5% goat serum in PBS with 0.4% Triton
X-100 (PBS-T) for 60 min followed by incubation in
PBS-T with a monoclonal antibody against BrdU (1:
10,000, Caltag Laboratories, CA, USA) at room tempera-
ture (RT) for 60 min, then for 24 h at 4°C. Sections
were rinsed in PBS and incubated with biotinylated anti-
mouse secondary in PBS-T (1: 1000, Vector, Auckland,
New Zealand) rinsed with PBS and incubated in Vectas-
tain Elite ABC reagents (1: 1000, Vector). BrdU-positive
cells were detected with diaminobenzidine (DAB) as
chromogen, creating a dark brown colour in BrdU-
positive nuclei.
For Ki-67 immunohistochemistry, tissue sections were
treated as stated above with the omission of the HCl
incubation step. Tissue sections were incubated with a
polyclonal antibody against Ki-67 in PBS-T (1: 5000,
Millipore, Darmstadt, Germany) for 60 min at RT and
then 4°C for 48 h followed by biotinylated anti-rabbit
secondary antibody (1: 1000). The Ki-67 positive cells
were detected with DAB.
Double-label fluorescence immunohistochemistry
Fluorescent immunohistochemistry was used to quantify
the extent of colocalization of BrdU and the neuronal
specific marker, NeuN. Free-floating tissue sections were
rinsed with 0.1 M PBS, incubated with 3% hydrogen
peroxide in PBS for 30 min, rinsed and incubated with 2
N HCl for 60 min at 37°C. After HCl incubation, sec-
tions were rinsed with Borate buffer solution followed
by PBS rinses, incubated with 0.3 M glycine in 0.4% Tri-
ton X-100 (PBS-T) for 30 min, and rinsed. Sections
were co-incubated with primary antibodies against anti-
rat BrdU (1:500, Abcam, Cambridge, UK) and anti-
mouse NeuN (1: 500, Millipore) in PBS-T, which con-
tained 10% bovine serum albumin (BSA), for 60 min at
R Ta n do v e r n i g h ta t4 ° Ct h e nr i n s e di nP B Sa n di n c u -
bated with biotinylated anti-rat secondary (1:300, Vec-
tor) in PBS-T for 90 min followed by co-incubation
with streptavidin Alexa 488 (1:1000; Invitrogen, CA,
USA) and anti-mouse Alexa 568 (1:500, Invitrogen) in
PBS-T for 60 min in the dark. Rinsed tissue sections
w e r em o u n t e do n t og e l a t i n - s u b b e ds l i d e sa n dc o v e r -
slipped in the dark using Vector Vectashield.
Data analysis
Each subregion of the hippocampus (CA1, CA3 and DG)
was analysed using a Nikon Eclipse E600 microscope and
the Neurolucida Software System (Microbrightfield,
VT, USA). Cell density estimates for each subregion were
determined by counting the immunopositive BrdU+, and
Ki-67+, cells from the pyramidal layer of CA1 and CA3 as
well as granule cell layer of the hippocampus. Cell quantifi-
cation consisted of using six gridded counting frames that
were within the specific subregion of the hippocampus.
Each individual counting frame measured 100 × 100 μm.
For all three subregions, we calculated the number of
immunopositive cells that were inside the counting frames,
in both the left and right hemisphere of each section. This
procedure was done in four to five sections throughout the
rostral hippocampus of each animal. The total number of
immunopositive cells across all counting frames was aver-
aged to give one mean value per animal per subregion. All
quantifications were performed using a 40× objective.
Furthermore, our cell quantification was performed with
adherence to appropriate stereological principles, which
included but was not limited to: (1) the presence of a
nucleus; (2) immunopositive cells were of homogeneously
shape; and (3) labelling intensities of immunopositive cells
were distinguishable from background staining. Figure 2A-
D is a photomicrograph that includes cells considered BrdU
+ and Ki67+ by both investigators conducting the analyses.
Lastly, the sex and hormonal condition of the animals was
unknown to the investigators conducting the analyses.
For immunofluorescence, each subregion of the hippo-
campus was analysed using a Nikon Eclipse 80i grid
confocal microscope equipped with an OptiGrid struc-
tured light source. Volocity Grid Confocal software
(Improvision, Warwickshire, UK) was used to perform
the analysis of Z-stacks measuring 10-12 μm collected
in two channels at 0.5 μm intervals using a 100× oil
objective. BrdU+ cells were selected in each subregion
and the number of cells co-expressing the neuronal
marker NeuN+ and BrdU+ were quantified. The immu-
nopositive cells were counted bilaterally within each
subregion, in four sections (45 μm thick), throughout
the hippocampus from each animal using an 80 × 100
μm counting frame.
Statistics
The detection of differences in the mean number of cells
per region per animal between groups was determined
using a three-factor ANOVA with sex, treatment and
brain region as fixed factors followed by post hoc pairwise
comparisons using P < 0.05 as the criterion for signifi-
cance. All post hoc comparisons were performed using a
Bonnferoni correction to control for familywise error.
Results
Neonatal oestradiol treatment increased BrdU+ cells in
the newborn female but not the male hippocampus
In order to assess the effects of oestradiol on cell prolif-
eration in developing hippocampus, pups were treated
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injection of BrdU and euthanized 6 h post-BrdU injec-
tion (for procedural timeline see Figure 1-A). A 2 × 2 ×
3 ANOVA indicated a significant main effect of sex [F
(1,54) = 28.43, P <0 . 0 0 1 ]c o n f i r m i n gt h a tm a l e sh a v ea
higher mean number of BrdU+ cells than females.
There was also a main effect of treatment [F (1,54) =
14.68, P < 0.001] with oestradiol increasing the mean
number of BrdU+ cells over vehicle. The three-way
interaction involving sex × treatment × brain region was
also significant [F (2,54) = 3.85, P <0 . 0 3 ] ,d u et ot h e
larger number of new cells being born in the DG com-
pared to CA1 and CA3. Regardless of the total number
of new cells, post hoc pairwise comparisons indicated
vehicle treated females had significantly fewer BrdU+
cells in all three subregions of the hippocampus than
either oestradiol treated females or males treated with
vehicle or oestradiol (Figure 3A-C; P < 0.01). In females,
oestradiol treatment increased the number of BrdU+
cells to the equivalent level seen in males, whereas there
was no effect of oestradiol on the number of BrdU+
cells in males (P> 0.05).
Cells generated in the presence of oestradiol survive for
both short- and long-term periods in the female
hippocampus
In order to assess the short- and long-term survival of
newborn cells in the neonatal hippocampus, pups were
treated with oestradiol followed 2 h later with a single
injection of BrdU on PN0 (for procedural timeline see
Figure 1-B). At PN4 (short-term period), males again
had more BrdU+ cell than females [F (1, 57) = 7.96, P <
0.007] and oestradiol treatment increased the number of
BrdU+ cells in DG and CA1 [F (1, 57) = 5.55, P < 0.03].
A significant three-way interaction [F (2,57) = 4.76, P <
0.03] followed by post hoc comparisons showed control
females had fewer BrdU+ cells in both the DG and CA1
than either oestradiol treated females or males
(Figure 4A-C; Post hoc, P < 0.01).
In order to assess whether cells generated under the
influence of oestradiol survive over a long period of
time, pups were treated with oestradiol and BrdU on
PN0 and PN1, then sacrificed on PN21 (for procedural
timeline see Figure 1C). The same general pattern of
effects observed on PN4 was again apparent on PN21,
Figure 2 Photomicrographs of 5-bromo-2-deoxyuridine (BrdU)+ and Ki-67+cells. (A) An example of a BrdU+cells versus background
staining at 40×. (B) 60× image of the demarked region seen in (A). (C) An example of a Ki-67+cell versus background at 40×. (D) 60× image of
the demarked region seen in (C).
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66) = 6.99, P < 0.01]; oestradiol treatment increased the
number of BrdU+ cells in all three subdivisions of the
hippocampus of females but not in males [F (2, 66) =
7.20, P < 0.002; Figure 5A-C, Post hoc, P < 0.01].
The majority of cells born in the presence of oestradiol
become neurons
In order to determine the fate of cells born on the first
few days of postnatal life, we performed fluorescent
immunohistochemistry and quantified the proportion of
BrdU+ cells that are also positive for NeuN, a marker of
mature neurons. The quantification of BrdU+/NeuN+
cells at PN21 indicated that both male and female
groups had proportionally similar numbers of BrdU+
cells that were co-labelled with NeuN in the pyramidal
cell layer of CA3 and the granular cell layer of DG
(73%; ± 2% in CA3 and 81%; ± 4% in the DG). However,
males had, overall, ~10% more BrdU+/NeuN+ cells than
females [F (1, 33) = 8.73, P < 0.01] with the DG having
Figure 3 Postnatal day (PN) 0 hormone treatment with
euthanasia 6 h after injection of 5-bromo-2-deoxyuridine
(BrdU). The mean (± standard error of mean) number of BrdU+
cells on day of birth in (A) CA1, (B) CA3 and (C) dentate gyrus.
Group with the (*) symbol is significantly different from the other
groups (ANOVA; P < 0.05).
Figure 4 Effects of oestradiol on short-term cell survival were
tested by postnatal day (PN) 0 hormone treatment followed
by euthanasia at PN4. The mean (± standard error of mean)
number of 5-bromo-2-deoxyuridine + cells on PN4 in (A) CA1, (B)
CA3 and (C) dentate gyrus. Group with the (*) symbol is significantly
different from the other groups (ANOVA; P < 0.05).
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NeuN in both sexes [F (2, 33) = 5,28, P < 0.05]. Post hoc
comparison following a significant three-way interaction
[F (2, 33) = 4.04, P < 0.03] revealed significantly fewer
co-labelled BrdU+/NeuN+ cells in area CA1 for control
females compared to either oestradiol treated females
and oestradiol treated males or control males (P <0 . 0 5 ;
Figure 6). In control females, 41% of cells in CA1
born on PN0-1 were identified as neurons on PN21.
In contrast, for females treated neonatally with oestra-
diol, 77% of the surviving cells were NeuN+, which is
comparable to the 80% and 78% observed in control and
oestradiol treated males, respectively.
The sex difference in cell proliferation is still apparent at
PN21 and increased in females by neonatal oestradiol
treatment
In order to assess whether the neonatal oestradiol-
induced increases in cell proliferation endure beyond
the period of steroid exposure, we quantified cells
expressing Ki-67, an endogenous protein that labels
actively proliferating cells, on PN21. Post hoc compari-
son following a significant three-way interaction [F
(2,36) = 4.49, P < 0.02] revealed that control females
had significantly fewer Ki-67+ cells in the DG, as com-
pared to control males and both neonatal oestradiol
treated females and males (P < 0.01; Figure 7). There
were no significant main effects for sex or treatment
(P’s> 0.05).
Inhibiting aromatase activity or blocking oestrogen
receptor binding reduces cell proliferation in the
developing male but not in the female hippocampus
In order to assess the impact of endogenous oestradiol on
cell proliferation, we quantified the number of BrdU+
cells in pups that were treated on PN0 and PN1 with for-
mestane (an aromatase inhibitor), tamoxifen (an oestro-
gen receptor (ER) antagonist) or vehicle, followed 2 h
later with an injection of BrdU (for procedural timeline
see Figure 1D). Treatment with formestane or tamoxifen
significantly reduced the number of BrdU+ cell compared
to controls [F(2, 152) = 30.63, P < 0.001]; this effect was
detected in all three subdivisions of the hippocampal
complex [F(2, 152) = 42.54, P < 0.001]. Post hoc compari-
son following a significant two-way interaction of sex ×
treatment [F (2, 152) = 30.97, P < 0.001] indicated that
the effect of formestane and tamoxifen treatment was
restricted to males (P < 0.01; Figure 8).
Discussion
In the present study, we found that exogenous oestra-
diol treatment promoted cell proliferation and survival
in the neonatal female but not the male hippocampus,
whereas antagonizing endogenous oestradiol synthesis
or action reduced cell proliferation in the male but not
in the female hippocampus. These results confirm and
extend our previous report describing a sex difference
and oestradiol-induced increase in the number of new
cells in the neonatal hippocampus [28] by confirming a
sex difference in cell genesis that is regulated by oestra-
diol. Our previous report included evidence of a male
biased sex difference and oestradiol-induced increase in
BrdU+/glial fibrillary acid (GFAP)+ expressing cells.
Figure 5 Effects of oestradiol on long-term survival and cell
fate were tested by postnatal day (PN) 0 and PN1 hormone
treatments followed by euthanasia 3 weeks later. The mean (±
standard error of mean) number of 5-bromo-2-deoxyuridine + cells
on PN21 in (A) CA1, (B) CA3 and (C) dentate gyrus. Group with the
(*) symbol is significantly different from the other groups (ANOVA; P
< 0.05).
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P N 4 ,b u td i dn o tc o - l a b e lt h e mw i t hB r d Ua st h e r e
was insufficient time for neurons born on PN0 to dif-
ferentiate. We found more NeuN+ cells in males, but
there was no significant increase following oestradiol
treatment at PN0-1. This is, again, most probably due
to insufficient time for neurons born on PN0 to differ-
entiate into neurons. Therefore our previous study did
not assess neurogenesis per se, as opposed to the later
developmental stage of PN21 used here. Moreover,
many GFAP expressing cells ultimately become neu-
rons [36] and it is possible the oestradiol-induced
increase we observed in BrdU+/GFAP+ cells was a
precursor to the later increase in BrdU+/NeuN+ cells
seen here. The current analysis is a more accurate
depiction of the fate of cells labelled at birth with
Figure 6 Confocal images of neurons in CA1 pyramidal layer cell layer of the hippocampus at 100× magnification. 5-bromo-2-
deoxyuridine (BrdU) immunofluorescence was combined with immunostaining for the neuronal marker, NeuN, at 3 weeks (PN21). (A) Confocal
image showing NeuN+ cells. (B) Confocal image showing BrdU+ cells. (C) Merged image of both BrdU+/NeuN+ cells. (D) Graph representing
total proportion of BrdU+/NeuN+ cells in CA1. Scale bars = 10 μm.
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previous results depict the fate of new cells within a
few days of birth.
There are two mechanisms by which an increase in
new cell number can occur; (1) an increased rate of
proliferation; and/or (2) a decreased rate of cell death.
In our previous study we observed a significant increase
in the number of new cells within 24 h of BrdU injec-
tion in males versus females and in females treated with
Figure 7 The mean (± standard error of mean) number of Ki-
67+ cells on postnatal day (PN) 21 in (A) CA1, (B) CA3 and (C)
dentate gyrus of PN0 and PN1 males and females treated with
oestradiol (E2) or control vehicle. Group with the (*) symbol is
significantly different from the other groups (ANOVA; P < 0.05).
Figure 8 Effects of antagonizing endogenous oestradiol were
tested by treatment on postnatal day (PN) 0 and PN1 with
formestane, tamoxifen or vehicle followed by euthanasia at
PN2. The mean (± standard error of mean) number of 5-bromo-2-
deoxyuridine (BrdU)+ cells on PN2 in (A) CA1, (B) CA3 and (C)
dentate gyrus. Females had significantly fewer BrdU+ cells
compared to males (ANOVA;
#P < 0.05). Treatment with formestane
and tamoxifen decreased BrdU+ cells in males, (*P < 0.01 compared
with all other groups).
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study the same pattern was observed at the even shorter
post-BrdU injection time point of 8 h. The half-life of
BrdU is approximately 2 h [37] whereas the cell cycle
requires approximately 24 h to complete [38]. Therefore,
differences in the number of BrdU+ cells within 24 h of
injection are generally interpreted as differences in the
rate of cell proliferation and not cell death [37]. Our
observation of more BrdU+ cells in males and oestra-
diol-treated females at both 8 h and 24 h post-BrdU
injection is, therefore, most consistent with a hormon-
ally mediated sex difference in cell proliferation. How-
ever, given that many new cells die shortly after being
born and would not be detected here, a potential contri-
bution of cell death to the sex differences observed can-
not be entirely ruled out.
While BrdU labelling offers many advantages, such as
long-term tracking of cell fate, there are also limitations
associated with potential toxicity and non-specific label-
ling [37]. In contrast, Ki-67 is an endogenous protein
that does not have any adverse effects on living cells
and is expressed in all phases of the cell cycle except
the resting phase and a short period at the beginning of
the G1 phase [39-41]. Thus, Ki-67 is not present in
quiescent and terminally differentiated cells and
increased numbers of Ki-67 expressing cells is consistent
with increased proliferation (but see [42]). In order to
determine if sex differences or hormonal modulation of
cell proliferation persisted outside of the early neonatal
period we quantified the number of Ki-67 expressing
cells in the hippocampus of 3-week-old animals and
found males and neonatally oestradiol-treated females
had more Ki-67+ cells than control females. This obser-
vation suggests a higher rate of cell proliferation was
organized during the neonatal sensitive period. A prece-
dent for the sexual differentiation of neurogenesis is evi-
dent in studies reporting differential sensitivity of adult
males and females to exogenous oestradiol treatment or
rates of cell birth and death in the DG. In the adult
female hippocampus, oestradiol stimulates cell prolifera-
tion [43], enhances cell survival [44] and increases den-
dritic spine synapse density [45-48]. In contrast, the
adult male hippocampus is insensitive to the spinogen-
esis or cell genesis inducing effects of oestradiol treat-
ment [44,49,50]. Oestradiol effects are mediated via
binding to the two oestrogen receptor isoforms, ERa
and ERb [51,52]. Both isoforms are distributed through-
out the brain, including the hippocampus, and both ERs
colocalize with the proliferative marker Ki-67 in the
adult hippocampus [50,53,54], although, there is a
region specific variation in their distribution [54-57].
Moreover, in the adult hippocampus, there are relatively
low levels ERa, which is in contrast to elevated
levels of ERa that occur during early postnatal
development [58-60]. Nonetheless, it is unclear which
receptor isoform is regulating the oestradiol’se f f e c t so n
cell proliferation in the developing hippocampus. Both
the short-term increase in the number of BrdU cells and
the higher density of Ki-67+ cells in oestradiol treated
females indicate a change in proliferative rates of pro-
genitor cells induced by oestradiol and this may be due
to a change in the duration of the progenitor cell cycle.
This was determined to be the case in neocortical neu-
rogenesis [61]. Oestradiol recruits cells into the S-phase
from either G1 or G0 phase, which effectively shortens
the G-phase, and results in an increased rate of prolif-
eration of dividing progenitor cells [61].
Both the amount of endogenous oestradiol and aro-
matase activity in the developing hippocampus are
extremely low compared to the hypothalamus and do
not appear to be sexually dimorphic [62], suggesting
that hippocampal sensitivity to oestradiol is high and
differs between the sexes, at least as indexed by hippo-
campal cell genesis. However, because oestradiol, the ER
antagonist and the aromatase inhibitor were all adminis-
tered systemically, it is possible the effects were not
mediated directly at the hippocampus but, instead, were
secondary to changes in other brain regions projecting
to the hippocampus. Cholinergic neurons of the medial
septum/diagonal band of Broca are essential for oestra-
diol-induced spinogenesis in adult CA1 hippocampus
[63] and cholinergic input modulates maturation and
integration of adult born DG granule cells [64]. Gonad-
ally intact males release more acetylcholine into the hip-
pocampus than females during locomotor tasks and this
sex difference is organized by oestradiol during develop-
ment [65,66]. The cholinergic system matures relatively
early and more new septal cholinergic neurons are born
in males during a brief period of gestation but the sex
difference does not persist into adulthood [67]. None-
theless, it is possible that the effects observed here are
the results of oestradiol-induced acetylcholine release
into the neonatal hippocampus during the early postna-
tal period. It is also possible that oestradiol is acting
outside the central nervous system. In adults, systemic
oestradiol alters the arterial cerebral blood flow in
females, but not in males [68-71], via an interaction
with nitric oxide [72,73]. Both ERa and ERb,a sw e l la s
the transmembrane G protein-coupled receptor, GPR30,
have been identified in blood vessels [74,75] and have
been implicated in the rapid vasodilator effects of oes-
tradiol [76]. One of the most powerful stimulators of
adult neurogenesis is exercise [77,78]; an effect believed
to be at least partly due to enhanced blood flow and
increased delivery of growth factors. Lastly, activation of
the stress axis has negative effects on adult neurogenesis
and the injection of BrdU and steroidal agents to neo-
nates is undoubtedly stressful. However, given that the
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groups, sex differences in stress responding can not
entirely explain the current results.
Neurogenesis in the adult hippocampus is restricted to
the proliferative zone of DG, with the majority of the
new cells becoming granule neurons [79,80]. A notable
difference in the profile of neurogenesis in the immature
brain is the presence of ongoing proliferation in CA1
and CA3 of Ammon’s horn. The colocalization of BrdU
with NeuN in these areas indicates that the cells born
early postnatally do become neurons but whether they
become pyramidal neurons or interneurons is unknown.
When, in development, this source of new cells is lost
and neurogenesis becomes restricted to the DG is also
unknown. An additional unknown is the ultimate role of
these enduring neurons in the adult hippocampal func-
tion. We observed almost twice as many new cells being
born in the neonatal male hippocampus compared to
the female. However, when the overall size of the hippo-
campus is compared in males and females, either devel-
opmentally or in adulthood, the sex difference, while
biased towards males, is of the order of 10%-12%
[15,21]. The magnitude of the sex difference in new
cells was just as strong at 3 weeks of age as when they
were just a few days old. Therefore, it does not appear
that these cells contribute significantly to the hippocam-
pal volume. The early postnatal period is a time of olfac-
tory imprinting and somatosensory stimulation from the
dam. The intensity of maternal licking and grooming is
greater toward male than female pups [81] and both the
nature and function of olfactory learning at this time is
likely to be different between the sexes. Whether the
role of new neurons born during this period is related
to olfactory or sensory learning remains to be
determined.
Conclusion
The hippocampus is a critical brain region involved in a
variety of cognitive functions (for example, learning and
memory) and both the physiologic and emotional
responses to stress. Abnormalities in the hippocampus
are strongly associated with affective disorders such as
major depressive disorder and schizophrenia [82-85], as
well as neurologic diseases such as Alzheimers. The
selective vulnerability of the hippocampus to hypoxia/
ischaemia following stroke, both perinatally and in
adulthood [86], further emphasizes the importance of
this critical brain region and the need to understand the
variables that impact upon it in both males and females.
Many of the sex differences observed in the adult hippo-
campus appear to be the result of early life events,
including the impact of gonadal steroid hormones on
neurogenesis during the early postnatal period.
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